Adiponectin attenuates lung fibroblasts activation and pulmonary fibrosis induced by paraquat

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Yao, Rong ^a   Cao, Yu ^a   He, Ya Rong ^a   Lau, Wayne Bond ^b   Zeng, Zhi ^a   Liang, Zong An ^a  

^a SICHUAN UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ALPHA SMOOTH MUSCLE ACTIN; CHOLECYSTOKININ OCTAPEPTIDE; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; FLUORESCEIN ISOTHIOCYANATE; GELATINASE B; LIPOCORTIN 5; MESSENGER RNA; PARAQUAT; SMALL INTERFERING RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; ACTIN; ADIPONECTIN RECEPTOR; ADIPOR1 PROTEIN, HUMAN; ADIPOR2 PROTEIN, HUMAN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; CTGF PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; TGFB1 PROTEIN, MOUSE; TIMP1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LOW DRUG DOSE; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG FIBROSIS SCORE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RATING SCALE; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CELL LINE; CELL SURVIVAL; CHEMICALLY INDUCED; DRUG EFFECTS; FIBROBLAST; GENETICS; LUNG; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY FIBROSIS; RANDOMIZATION; RNA INTERFERENCE;

MUS;

ACTINS; ADIPONECTIN; ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; COLLAGEN TYPE III; CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLASTS; HUMANS; LUNG; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; PARAQUAT; PULMONARY FIBROSIS; RANDOM ALLOCATION; RECEPTORS, ADIPONECTIN; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84929094253     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125169     Document Type: Article

References (29)

1. Dinis-Oliveira RJ, Duarte JA, Sanchez-Navarro A, Remiao F, Bastos ML, Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol. 2008; 38: 13-71. PMID: 18161502
2. Hoet PH, Lewis CP, Demedts M, Nemery B. Putrescine and paraquat uptake in human lung slices and isolated type II pneumocytes. Biochem Pharmacol. 1994; 48: 517-524. PMID: 8068038
3. Yamashita M, Yamashita M, Ando Y. A long-term follow-up of lung function in survivors of paraquat poisoning. Hum Exp Toxicol. 2000; 19: 99-103. PMID: 10773838
4. Suntres ZE. Role of antioxidants in paraquat toxicity. Toxicology. 2002; 180: 65-77. PMID: 12324200
5. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends In Endocrinology And Metabolism. 2002; 13: 84-89. PMID: 11854024
6. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond). 2006; 110: 267-278. PMID: 16464169
7. Robinson K, Prins J, Venkatesh B. Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit Care. 2011; 15: 221. doi: 10.1186/cc10021 PMID: 21586104
8. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology. 2003; 125: 1796-1807. PMID: 14724832
9. Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol. 2007; 27: 1910-1917. PMID: 17626903
10. Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, et al. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arteriosclerosis Thrombosis And Vascular Biology. 2008; 28: 863-870. doi: 10.1161/ATVBAHA.107.156687 PMID: 18309113
11. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988; 41: 467-470. PMID: 3366935
12. Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest. 2004; 125: 754-765. PMID: 14769761
13. Meyer-Ter-Vehn T, Gebhardt S, Sebald W, Buttmann M, Grehn F, Schlunck G, et al. p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci. 2006; 47: 1500-1509. PMID: 16565385
14. Giannandrea M, Parks WC. Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech. 2014; 7: 193-203. doi: 10.1242/dmm.012062 PMID: 24713275
15. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003; 28: 12-24. PMID: 12495928
16. Ruiz V, Ordonez RM, Berumen J, Ramirez R, Uhal B, Becerril C, et al. Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol. 2003; 285: L1026-1036. PMID: 12882763
17. Keeley EC, Mehrad B, Strieter RM. The role of fibrocytes in fibrotic diseases of the lungs and heart. Fibrogenesis Tissue Repair. 2011; 4: 2. doi: 10.1186/1755-1536-4-2 PMID: 21219601
18. Lai CK, Wallace WD, Fishbein MC. Histopathology of pulmonary fibrotic disorders. Seminars In Respiratory And Critical Care Medicine. 2006; 27: 613-622. PMID: 17195138
19. Krenning G, Moonen JRAJ, Harmsen MC. Pleiotropism of Adiponectin Inflammation, Neovascularization, and Fibrosis. Circulation Research. 2009; 104: 1029-1031. doi: 10.1161/CIRCRESAHA.109.198044 PMID: 19423859
20. Luo KX. Ski and SnoN: negative regulators of TGF-beta signaling. Current Opinion In Genetics & Development. 2004; 14: 65-70.
21. Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis - The myofibroblast in focus. Chest. 2007; 132: 1311-1321. PMID: 17934117
22. Bronnum H, Eskildsen T, Andersen DC, Schneider M, Sheikh SP. IL-1beta suppresses TGF-beta-mediated myofibroblast differentiation in cardiac fibroblasts. Growth Factors. 2013; 31: 81-89. doi: 10.3109/08977194.2013.787994 PMID: 23734837
23. Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, et al. Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenesis Tissue Repair. 2011; 4: 4. doi: 10.1186/1755-1536-4-4 PMID: 21284856
24. Brigstock DR. Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal. 2009; 3: 5-18. doi: 10.1007/s12079-009-0043-9 PMID: 19294531
25. George J, Tsutsumi M. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther. 2007; 14: 790-803. PMID: 17344905
26. Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol. 2004; 15: 1430-1440. PMID: 15153554
27. Phan SH. The myofibroblast in pulmonary fibrosis. Chest. 2002; 122: 286S-289S. PMID: 12475801
28. Pardo A, Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc. 2006; 3: 383-388. PMID: 16738205
29. Lim DH, Cho JY, Miller M, McElwain K, McElwain S, Broide DH. Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2006; 291: L265-271. PMID: 16825657